AT
Avenue Therapeutics, Inc.
ATXI · OTC
$0.54 +12.69% (+$0.06)
1M +19.39%
Market Cap $1.57M
P/E Ratio -
Div. Yield -
ROE 155.23%
Bulios Fair Price
$0.69
28.2% upside
Trenutna cena
$0.54
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ATXI trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
71 /100
Cheap P/B 2.77x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 22.30%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 140.54%
ROIC 544.82%
Asset turnover 0.00x
Debt
88 /100
Low Current ratio 1.38x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
34 /100
Moderate Profitable years 0
Beta -0.17x
EPS volatility 51.26%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ATXI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alexandra MacLean
Employees
1
Headquarters
Bay Harbor Islands
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report